135 related articles for article (PubMed ID: 37872057)
1. Corrigendum to "The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics" [Int. Immunopharmacol. 118 (2023) 110081].
Ghosh M; Rana S
Int Immunopharmacol; 2023 Dec; 125(Pt A):111089. PubMed ID: 37872057
[No Abstract] [Full Text] [Related]
2. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Ghosh M; Rana S
Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
[TBL] [Abstract][Full Text] [Related]
3. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
Zhang Y; Ji T; Ma S; Wu W
Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation" [Int. Immunopharmacol. 73 (2019) 304-311].
Zheng Y; Zhu G; He J; Wang G; Li D; Zhang F
Int Immunopharmacol; 2020 Nov; 88():107004. PubMed ID: 32950402
[No Abstract] [Full Text] [Related]
5. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
Kawai M; Quincy DA; Lane B; Mollison KW; Or YS; Luly JR; Carter GW
J Med Chem; 1992 Jan; 35(2):220-3. PubMed ID: 1732540
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
Int Immunopharmacol; 2020 Jul; 84():105962. PubMed ID: 31948857
[No Abstract] [Full Text] [Related]
7. Corrigendum to "2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from the root of Averrhoa carambola L., protects against diabetic kidney disease by inhibiting TLR4/TGFβ signaling pathway" [Int. Immunopharmacol. 80 (2020) 106120].
Zhang H; Lu S; Chen L; Huang X; Jiang L; Li Y; Liao P; Wu X; Zhou X; Qin L; Wei J; Huang R
Int Immunopharmacol; 2024 Mar; 129():111667. PubMed ID: 38350758
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
[No Abstract] [Full Text] [Related]
9. Corrigendum to "7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signaling" [Int. Immunopharmacol. 107 (2022) 108557].
Chen J; Zhu G; Sun Y; Wu Y; Wu B; Zheng W; Ma X; Zheng Y
Int Immunopharmacol; 2023 Sep; 122():110702. PubMed ID: 37544812
[No Abstract] [Full Text] [Related]
10. Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in 3T3-L1 adipocytes.
Zhang XY; Liu Y; He T; Yang TT; Wu J; Cianflone K; Lu HL
Biomed Pharmacother; 2018 Jul; 103():955-964. PubMed ID: 29710512
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139].
Feng Q; Hu K; Hu H; Lu Y; Zhang H; Wang G; Zhang Q; Xu Z; Gao X; Jia X; Zhu H; Song D; Yi H; Peng Y; Wu X; Li B; Zhu W; Shi J
Int Immunopharmacol; 2024 Jun; ():112499. PubMed ID: 38909009
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis" [Int. Immunopharmacol. 115 (2023) 109731].
Wang Y; Chen Z; Luo J; Zhang J; Sang AM; Cheng ZS; Li XY
Int Immunopharmacol; 2023 Apr; 117():110002. PubMed ID: 36925352
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation" [Int. Immunopharmacol. 8 (2008) 1854-1858].
Sun Q; Zheng Y; Liu Q; Cao X
Int Immunopharmacol; 2020 Apr; 81():106193. PubMed ID: 32139322
[No Abstract] [Full Text] [Related]
14. C5a receptor antagonists for the treatment of inflammation.
Sumichika H
Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum to "Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/SCD1 signaling pathway and modulating gut microbiota" [Int. Immunopharmacol. 99 (2021) 108065].
Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
Int Immunopharmacol; 2023 Dec; 125(Pt A):111084. PubMed ID: 37879973
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Ghrelin attenuates secondary brain injury following intracerebral hemorrhage by inhibiting NLRP3 inflammasome activation and promoting Nrf2/ARE signaling pathway in mice" [Int. Immunopharmacol. 79 (2020) 106180].
Cheng Y; Chen B; Xie W; Chen Z; Yang G; Cai Y; Shang H; Zhao W
Int Immunopharmacol; 2020 Jul; 84():106461. PubMed ID: 32278662
[No Abstract] [Full Text] [Related]
17. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo.
Soruri A; Kiafard Z; Dettmer C; Riggert J; Köhl J; Zwirner J
J Immunol; 2003 Mar; 170(6):3306-14. PubMed ID: 12626590
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
Farkas I; Baranyi L; Liposits ZS; Yamamoto T; Okada H
Neuroscience; 1998 Oct; 86(3):903-11. PubMed ID: 9692726
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats" [Int. Immunopharmacol. 124(Part A) (2023) 110945].
Raafat RS; Habib MZ; AbdElfattah AA; Olama NK; Abdelraouf SM; Hendawy N; Kamal KA; Nawishy SA; Aboul-Fotouh S
Int Immunopharmacol; 2023 Dec; 125(Pt B):111203. PubMed ID: 37978013
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Isosteroid alkaloids with different chemical structures from Fritillariae cirrhosae bulbus alleviate LPS-induced inflammatory response in RAW 264.7 cells by MAPK signaling pathway" [Int. Immunopharmacol. 78 (2020) 106047].
Liu S; Yang T; Ming TW; Gaun TKW; Zhou T; Wang S; Ye B
Int Immunopharmacol; 2020 Jul; 84():106482. PubMed ID: 32278661
[No Abstract] [Full Text] [Related]
[Next] [New Search]
